Accent Microcell Ltd (ACCENTMIC) — share price & stock analysis
Profits are up 47% in two years, most of that is already in the price.
Accent Microcell Ltd (ACCENTMIC) trades at ₹496 as of 1 July 2026, up 84% over the past year — beating NIFTY 500 for 44 weeks. The machine reads this as steady growth, fairly priced: profits are up 47% in two years, most of that is already in the price. It trades at a P/E of 27.2× (the 64th percentile of its own range); the price is in Stage 2 — advancing, 51 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 62/100 (mostly improving).
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Market cap
- ₹1,191 Cr
- P/E
- 27.2×
- ROE
- 18.6%
- vs own history (since 2024)
- 64th pctile
- Book value / share
- ₹115
- EPS (TTM)
- ₹18.3
- 10-yr median P/E
- 20.0×
- Revenue (FY26)
- ₹349 Cr
- Profit after tax (FY26)
- ₹44 Cr
- Weinstein stage
- Stage 2 (51 weeks)
- Data as of
- 1 July 2026
Profits swing violently in this business — margins swinging 11 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit
Where the clock stands now: earnings sit at 100% of their historical range, margins are the best ever printed, and the market pays mid-range (64th percentile). That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit
4 of the 6 things we track are currently moving the right way — most of the dashboard is turning up.
Where the levels actually stand: ROCE 25% — a high-quality engine; effectively no debt; margins at an all-time high. Momentum says which way things are moving; these say where they are.
Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).
Most of this rally is re-rating, not earnings
Since May 2024, the stock is up 60% while earnings per share grew 21%. The difference is re-rating — investors paying more for the same rupee of profit.pricettm_eps
That works until it doesn’t: from here, earnings have to do the lifting, because the multiple has already done its part.
Today’s P/E of 27.2× is the middle of its own range against its own history since 2024 (64th percentile) — neither a bargain nor a stretch, by its own standards.pe_ratio
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
| Period | Price (₹) | EPS (TTM) (₹) | P/E (×) |
|---|---|---|---|
| May 24 | 277 | – | 33.6 |
| May 24 | 256 | 15.1 | 16.9 |
| Jun 24 | 264 | 15.2 | 17.4 |
| Jul 24 | 282 | 15.1 | 18.6 |
| Aug 24 | 269 | 15.1 | 17.8 |
| Aug 24 | 266 | 12.9 | 20.6 |
| Sep 24 | 266 | 12.9 | 20.6 |
| Oct 24 | 266 | 12.9 | 20.6 |
| Oct 24 | 245 | 13.5 | 18.1 |
| Nov 24 | 227 | 13.5 | 16.8 |
| Dec 24 | 252 | 13.5 | 18.6 |
| Dec 24 | 259 | 13.6 | 19.1 |
| Jan 25 | 254 | 13.6 | 18.7 |
| Feb 25 | 246 | 13.6 | 18.1 |
| Feb 25 | 206 | 13.6 | 15.2 |
| Mar 25 | 195 | 13.5 | 14.4 |
| Apr 25 | 192 | 13.6 | 14.1 |
| May 25 | 195 | 13.6 | 14.3 |
| May 25 | 234 | 13.8 | 16.9 |
| Jun 25 | 229 | 13.8 | 16.6 |
| Jul 25 | 270 | 13.8 | 19.6 |
| Jul 25 | 274 | 13.8 | 19.9 |
| Aug 25 | 291 | 13.8 | 21.1 |
| Sep 25 | 279 | 13.8 | 20.2 |
| Sep 25 | 245 | 13.7 | 17.8 |
| Oct 25 | 284 | 14.5 | 19.6 |
| Nov 25 | 281 | 14.4 | 19.5 |
| Nov 25 | 327 | 14.5 | 22.6 |
| Dec 25 | 334 | 14.5 | 23.1 |
| Jan 26 | 352 | 14.4 | 24.4 |
| Feb 26 | 332 | 14.5 | 23.0 |
| Feb 26 | 327 | 14.5 | 22.6 |
| Feb 26 | 335 | 14.4 | 23.2 |
| Mar 26 | 346 | 14.5 | 23.9 |
| Apr 26 | 381 | 14.5 | 26.3 |
| Apr 26 | 434 | – | 30.0 |
| Apr 26 | 425 | – | 29.4 |
| May 26 | 436 | 18.3 | 23.9 |
| Jun 26 | 477 | 18.3 | 26.1 |
| Jun 26 | 459 | 18.3 | 25.1 |
| Jun 26 | 464 | 18.3 | 25.4 |
| Jul 26 | 496 | 18.3 | 27.1 |
Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots (the window starts at the first stable snapshot — earlier IPO-era share-count revisions are excluded, since they are not earnings events); between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (20×).
Stage 2: the trend is up, and has been for 51 weeks
STAGE 2 · ADVANCING · 51 WEEKSPrice trends have a life cycle: they base (1), advance (2), top out (3) and decline (4). This chart is in Stage 2: advancing — 51 weeks so far, confirmed.stage
The price sits above its rising 200-day average (₹370 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200
Beating NIFTY 500 for 44 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield
What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
| Period | Price (₹) | 200-DMA (₹) | 50-DMA (₹) | Stage |
|---|---|---|---|---|
| Dec 23 | 298 | 298 | 298 | 4 |
| Jan 24 | 316 | 296 | 291 | 4 |
| Jan 24 | 288 | 296 | 293 | 4 |
| Feb 24 | 260 | 292 | 280 | 4 |
| Mar 24 | 260 | 287 | 271 | 4 |
| Mar 24 | 233 | 281 | 256 | 4 |
| Apr 24 | 249 | 277 | 254 | 4 |
| May 24 | 277 | 275 | 256 | 4 |
| May 24 | 256 | 275 | 266 | 4 |
| Jun 24 | 264 | 274 | 266 | 4 |
| Jul 24 | 282 | 274 | 269 | 4 |
| Aug 24 | 269 | 274 | 270 | 4 |
| Aug 24 | 266 | 272 | 266 | 4 |
| Sep 24 | 266 | 271 | 265 | 4 |
| Oct 24 | 266 | 270 | 265 | 4 |
| Oct 24 | 245 | 268 | 261 | 4 |
| Nov 24 | 227 | 264 | 251 | 4 |
| Dec 24 | 252 | 261 | 246 | 4 |
| Dec 24 | 259 | 259 | 248 | 4 |
| Jan 25 | 254 | 260 | 253 | 4 |
| Feb 25 | 246 | 258 | 251 | 4 |
| Feb 25 | 206 | 253 | 237 | 4 |
| Mar 25 | 195 | 246 | 220 | 4 |
| Apr 25 | 192 | 239 | 207 | 4 |
| May 25 | 195 | 235 | 206 | 4 |
| May 25 | 234 | 231 | 209 | 4 |
| Jun 25 | 229 | 231 | 218 | 4 |
| Jul 25 | 270 | 233 | 230 | 4 |
| Jul 25 | 274 | 238 | 249 | 4 |
| Aug 25 | 291 | 246 | 270 | 2 |
| Sep 25 | 279 | 252 | 279 | 2 |
| Sep 25 | 245 | 253 | 270 | 2 |
| Oct 25 | 284 | 254 | 265 | 2 |
| Nov 25 | 281 | 256 | 270 | 2 |
| Nov 25 | 327 | 264 | 288 | 2 |
| Dec 25 | 334 | 274 | 312 | 2 |
| Jan 26 | 352 | 284 | 327 | 2 |
| Feb 26 | 332 | 290 | 329 | 2 |
| Feb 26 | 335 | 296 | 329 | 2 |
| Mar 26 | 346 | 301 | 334 | 2 |
| Apr 26 | 381 | 308 | 343 | 2 |
| Apr 26 | 436 | 323 | 379 | 2 |
| May 26 | 441 | 339 | 408 | 2 |
| Jun 26 | 472 | 352 | 424 | 2 |
| Jun 26 | 461 | 357 | 431 | 2 |
| Jun 26 | 452 | 363 | 435 | 2 |
| Jul 26 | 496 | 370 | 444 | 2 |
Profits have grown in 6 of the last 7 years — compounding so far, on a short record
Over 7 years, sales went from ₹114 Cr to ₹349 Cr (about 17% a year), and profit from ₹4.0 Cr to ₹44.0 Cr.revenuenet_profit
Margins widened 11 points along the way — growth with improving economics.operating_profit
Data: Revenue by year
| Period | Revenue (₹ Cr) |
|---|---|
| FY19 | 114 |
| FY20 | 131 |
| FY21 | 133 |
| FY22 | 166 |
| FY23 | 197 |
| FY24 | 246 |
| FY25 | 265 |
| FY26 | 349 |
Data: Profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| FY19 | 4 |
| FY20 | 4 |
| FY21 | 5 |
| FY22 | 6 |
| FY23 | 12 |
| FY24 | 30 |
| FY25 | 33 |
| FY26 | 44 |
Data: OPM % by year
| Period | OPM % (%) |
|---|---|
| FY19 | 5.3 |
| FY20 | 6.9 |
| FY21 | 8.3 |
| FY22 | 7.8 |
| FY23 | 9.6 |
| FY24 | 15.9 |
| FY25 | 15.8 |
| FY26 | 16.3 |
Sales exploded 51% last quarter
Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year.revenue
Data: Quarterly sales
| Period | Revenue (₹ Cr) | YoY growth (%) |
|---|---|---|
| Sep 23 | 107 | – |
| Mar 24 | 139 | – |
| Sep 24 | 126 | 17.8 |
| Mar 25 | 139 | 0.0 |
| Sep 25 | 139 | 10.3 |
| Mar 26 | 210 | 51.1 |
Margins have been rebuilt — 7.8% in FY22 to 16.3% now
Of every ₹100 of sales, the company keeps ₹15.6 as operating profit (a year ago it kept ₹16.7).opm_pct
Zoom out and this is the page's quiet hero: annual operating margin bottomed at 7.8% in FY22 and has been rebuilt to 16.3% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit
The gross margin moved the same way (40% → 37%), so this is about input costs and pricing power — the raw-material equation worsened.gpm_pctopm_pct
Data: Three margins, quarterly
| Period | Gross (%) | Operating (%) | Net (%) |
|---|---|---|---|
| Mar 23 | 32.6 | 14.8 | 12.0 |
| Sep 23 | 45.9 | 18.3 | 14.0 |
| Mar 24 | 36.5 | 14.4 | 11.6 |
| Sep 24 | 37.9 | 14.9 | 13.1 |
| Mar 25 | 39.9 | 16.7 | 12.0 |
| Sep 25 | 40.0 | 17.2 | 13.0 |
| Mar 26 | 36.9 | 15.6 | 12.3 |
Profit exploded 53% — mostly from selling more
Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year.net_profit
Data: Quarterly profit after tax
| Period | PAT (₹ Cr) | YoY growth (%) |
|---|---|---|
| Sep 23 | 14.0 | – |
| Mar 24 | 16.0 | – |
| Sep 24 | 16.0 | 14.3 |
| Mar 25 | 17.0 | 6.3 |
| Sep 25 | 18.0 | 12.5 |
| Mar 26 | 26.0 | 52.9 |
The single biggest driver was selling more.
Data: Where the profit change came from (Mar 25 → Mar 26)
| Component | Effect (₹ Cr) |
|---|---|
| PAT Mar 25 | 17 |
| More sales | +12 |
| Thinner margins | −2 |
| Other income | +1 |
| Depreciation | −1 |
| Tax | −1 |
| PAT Mar 26 | 26 |
Most of the profit becomes cash — but not all
Over the last 5 profitable years, the business reported ₹125 Cr of profit and collected ₹78.0 Cr of operating cash — about 62% conversion.operating_cash_flownet_profit
The wrinkle is the latest year: FY26 collected ₹19.0 Cr against ₹44.0 Cr of reported profit — about 43%. One year isn’t a trend, but it is the line to watch.operating_cash_flownet_profit
The gap sits in receivables: customers now take 95 days to pay, up from 90. Profit booked, cash pending.debtor_days
Data: Cash collected vs profit reported (annual)
| Period | Operating cash flow (₹ Cr) | Profit after tax (₹ Cr) |
|---|---|---|
| FY19 | 6.0 | 4.0 |
| FY20 | 5.0 | 4.0 |
| FY21 | 5.0 | 5.0 |
| FY22 | 15.0 | 6.0 |
| FY23 | 8.0 | 12.0 |
| FY24 | 11.0 | 30.0 |
| FY25 | 25.0 | 33.0 |
| FY26 | 19.0 | 44.0 |
The cash cycle is stable
One rupee now takes about 117 days to go out the door as materials and come back as collected cash — down from 124 days the year before.cash_conversion_cycle
The biggest mover: inventory moving faster off the shelf (76 → 55 days).inventory_days
Data: Days of cash locked up (annual)
| Period | Customers owe (debtor days) (days) | Stock on shelf (inventory days) (days) | We owe suppliers (payable days) (days) |
|---|---|---|---|
| FY19 | 70.0 | 67.0 | 89.0 |
| FY20 | 60.0 | 78.0 | 80.0 |
| FY21 | 35.0 | 128 | 74.0 |
| FY22 | 38.0 | 128 | 97.0 |
| FY23 | 56.0 | 128 | 106 |
| FY24 | 80.0 | 83.0 | 48.0 |
| FY25 | 90.0 | 76.0 | 42.0 |
| FY26 | 95.0 | 55.0 | 33.0 |
Building hard — new capacity is under construction
The productive asset base has gone from ₹30.0 Cr (FY19) to ₹53.0 Cr, with another ₹102 Cr of capacity under construction right now.fixed_assetscwip
Work-in-progress is 192% of the existing asset base — that is a serious bet on future demand. Capacity like this shows up in sales with a lag; it is tomorrow’s growth being paid for today.cwip
The build is bigger than the cash engine: investing outflows (₹140 Cr) exceeded operating cash (₹55.0 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow
Data: Assets in place vs under construction (annual)
| Period | Fixed assets (₹ Cr) | Under construction (CWIP) (₹ Cr) |
|---|---|---|
| FY19 | 30.0 | 0.0 |
| FY20 | 29.0 | 0.0 |
| FY21 | 30.0 | 0.0 |
| FY22 | 30.0 | 0.0 |
| FY23 | 31.0 | 0.0 |
| FY24 | 29.0 | 2.0 |
| FY25 | 48.0 | 13.0 |
| FY26 | 53.0 | 102 |
Almost no debt — this company cannot be killed by a bad year
For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹32.0 Cr to ₹1.0 Cr over the window.borrowings
Data: Total borrowings (annual)
| Period | Borrowings (₹ Cr) |
|---|---|
| FY19 | 32.0 |
| FY20 | 30.0 |
| FY21 | 31.0 |
| FY22 | 24.0 |
| FY23 | 23.0 |
| FY24 | 13.0 |
| FY25 | 2.0 |
| FY26 | 1.0 |
Data: Debt vs shareholders’ money (annual)
| Period | Debt ÷ equity (x) |
|---|---|
| FY19 | 1.5 |
| FY20 | 1.2 |
| FY21 | 1.2 |
| FY22 | 0.8 |
| FY23 | 0.5 |
| FY24 | 0.1 |
| FY25 | 0.0 |
| FY26 | 0.0 |
Every ₹100 kept in the business now earns ₹25 — and the number is rising
Return on capital employed is 25.0% (a year ago: 24.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct
Data: Returns on capital (annual)
| Period | ROCE (%) |
|---|---|
| FY20 | 18.0 |
| FY21 | 17.0 |
| FY22 | 19.0 |
| FY23 | 27.0 |
| FY24 | 31.0 |
| FY25 | 24.0 |
| FY26 | 25.0 |
Big money is quietly accumulating
Promoters hold 55.5%, essentially unchanged. Foreign funds own 0.6%, domestic funds 3.6%.promoters_pctfiis_pctdiis_pct
Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t.
Data: Who holds the shares, quarterly
| Period | Promoters (%) | Foreign funds (%) | Domestic funds (%) |
|---|---|---|---|
| Mar 24 | 55.1 | 0.0 | 1.6 |
| Sep 24 | 55.1 | 0.0 | 1.7 |
| Mar 25 | 55.1 | 0.0 | 2.2 |
| Jun 25 | 55.1 | 0.0 | 2.9 |
| Sep 25 | 55.4 | 0.0 | 3.3 |
| Dec 25 | 55.4 | 0.3 | 3.6 |
| Mar 26 | 55.5 | 0.6 | 3.6 |
- Promoters are not selling. Their stake has moved 0.4 points or less in 7 quarters — it sits at 55.5%.promoters_pct
- Foreign funds have neither piled in nor fled — their stake has held near 0.6% for 7 quarters. No smart-money signal, in either direction.fiis_pct
A good business — the question is the price
The numbers are genuinely mixed, and the price already assumes the good news continues.
Best thing in the data: debt improving (0.01× → 0×).borrowings
Biggest worry: free cash flow falling (₹16.0 Cr → ₹−30.0 Cr).operating_cash_flow
Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.
Straight answers from the data
What does Accent Microcell Ltd do?
Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]. It is listed in the Pharma - Formulators sector with a market capitalisation of ₹1,191 Cr.
What is Accent Microcell Ltd's share price?
As of 1 July 2026, Accent Microcell Ltd trades at ₹496, up 84% over the past year, with a market capitalisation of ₹1,191 Cr. Beating NIFTY 500 for 44 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.
What is Accent Microcell Ltd's share price target?
Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Accent Microcell Ltd's intrinsic value at ₹692 per share under base assumptions (bear ₹293, bull ₹692), against the current price of ₹496 — a 50% margin of safety. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.
Is Accent Microcell Ltd stock overvalued or undervalued?
Accent Microcell Ltd trades at a P/E of 27.2× — the 64th percentile of its own 2.1-year trading range (median 20.0×), which is above the middle of its own historical range. Most of this rally is re-rating, not earnings. Since May 2024, the stock is up 60% while earnings per share grew 21%. The difference is re-rating — investors paying more for the same rupee of profit. Note the short 2.1-year valuation record.
What did Accent Microcell Ltd report in its latest quarterly results?
In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year. Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.
Is Accent Microcell Ltd growing?
Sales exploded 51% last quarter. Mar 26 sales were ₹210 Cr, up 51% on the same quarter last year.
Are Accent Microcell Ltd's profits growing?
Profit exploded 53% — mostly from selling more. Mar 26 profit after tax was ₹26.0 Cr, up 53% year on year.
What are Accent Microcell Ltd's operating margins?
Margins have been rebuilt — 7.8% in FY22 to 16.3% now. In the most recent quarter, of every ₹100 of sales, the company keeps ₹15.6 as operating profit (a year ago it kept ₹16.7).
What is Accent Microcell Ltd's long-term growth record?
Revenue grew from ₹114 Cr in FY19 to ₹349 Cr in FY26 — a 17.3% compound annual growth rate over 7 years. Profit after tax compounded at 40.9% over the same period (₹4 Cr → ₹44 Cr).
Is Accent Microcell Ltd stock in an uptrend?
Stage 2: the trend is up, and has been for 51 weeks. Accent Microcell Ltd is in Stage 2 — advancing, 51 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).
Why is Accent Microcell Ltd stock rising?
The price is up 84% over the past year, in a confirmed Stage 2 uptrend (51 weeks), and has beaten NIFTY 500 for 44 weeks. Since 2024, the price is up 60% while earnings per share moved 21%.
Is Accent Microcell Ltd beating the NIFTY 500?
Yes — beating NIFTY 500 for 44 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.
Where is Accent Microcell Ltd in its business cycle?
The data reads Accent Microcell Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company, valuation at the 64th percentile. Profits swing violently in this business — margins swinging 11 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.
Who owns Accent Microcell Ltd — what is the promoter holding?
Promoters hold 55.5%, essentially unchanged. Foreign funds own 0.6%, domestic funds 3.6%. Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t. Shareholding is from Screener's quarterly filings data.
Does Accent Microcell Ltd have too much debt?
Almost no debt — this company cannot be killed by a bad year. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹32.0 Cr to ₹1.0 Cr over the window.
What is the bull case for Accent Microcell Ltd?
Profits are up 47% in two years, most of that is already in the price. Best thing in the data: debt improving (0.01× → 0×). Sales exploded 51% last quarter.
What is the bear case for Accent Microcell Ltd — what could break the story?
Biggest worry: free cash flow falling (₹16.0 Cr → ₹−30.0 Cr). Two quarters of profit reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 26%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.
Is Accent Microcell Ltd a stock worth studying right now?
Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: a good business — the question is the price. The numbers are genuinely mixed, and the price already assumes the good news continues. Across the 7-model scorecard the composite research signal is on watch at 73% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.